RELEASES
-
TRIMIRA Partners With NDC to Distribute Identafi™ 3000 Oral Cancer Detection Device
NDC Is Largest Organization of Independent Medical, Dental, Lab Distributors
For further information contact:
Fred Iannotti
802-888-0085
fiannotti@planningsource.comHOUSTON, June 23, 2009 — TRIMIRA LLC has partnered with National Distribution & Contracting, Inc. (NDC) to distribute TRIMIRA's next-generation oral cancer detection device, Identafi™ 3000.
"Trimira provides the NDC distributor members the opportunity to present an innovative product to their customers. Identafi™ 3000 features the latest technology in oral cancer screening in which early diagnosis is critical," states Lori Paulson, VP of marketing & dental programs for NDC, which is the largest organization of independent dental, medical, surgical, veterinary, and laboratory supply distributors in the U.S.
"The dental community has demonstrated huge interest in Identafi 3000's multispectral fluorescence and reflectance technology," TRIMIRA VP, Marketing Jerry S. Trzeciak said. "Identafi 3000's three distinct color wavelengths enhance the visualization of mucosal abnormalities, such as oral cancer or premalignant dysplasia that may not be apparent to the naked eye."
Trzeciak noted that Identafi 3000 was discussed at Tufts' School of Dental Medicine's recent symposium on oral cancer.
Trzeciak said Identafi 3000 was designed for early detection use by dentists and hygienists, primary care practitioners, oral surgeons, and otolaryngologists. "The combination of all three multispectral wavelengths provides the clinician with more visual information resulting in fewer false positives," he said, "and increased confidence for recommending biopsies as well as reducing the need for follow-up biopsies." Identafi 3000's features and benefits include:
- Small, compact size
- Space-saving design fits any treatment room
- Reasonable price of system and disposables
- Real-time results
- Ergonomic design
- The combination of all three multispectral wavelengths provides the clinician with more visual information resulting in fewer false positives and increased confidence for recommending biopsies and reducing the need for follow-up biopsy
- Avoids the need for messy, bad-tasting dyes/solutions
- Expands practice treatment offerings
- In-office training and marketing materials provided
- Enhances perception of practice as the “highest standard of care”
About National Distribution & Contracting, Inc. (NDC)
NDC, Inc. represents over 284 distributors, the largest organization of independent medical, surgical, veterinary, dental and laboratory supply distributors in the United States. NDC provides a unique collection of business services including master distribution and logistics on behalf of distributors and manufacturers serving healthcare providers throughout the United States, Canada, Puerto Rico, and parts of Central America.
Visit NDC at: www.ndc-inc.comAbout TRIMIRA™ LLC
TRIMIRA™ LLC is a subsidiary of Remicalm LLC, a privately held medical diagnostic and imaging device company. Other subsidiaries are working on screening and diagnostic devices for skin, cervical, gastrointestinal, and bladder cancers. Remicalm, as the parent company, has licensed exclusive use of certain of its patents and patents pending for use as a cervical cancer product to be later expanded to include additional epithelial-based cancers. Remicalm's core technologies are based on high-speed, high-resolution capabilities from its patented optical processing technology platforms and include the ability to read metabolic and physiologic differences in diseased and healthy tissue in the human body.
Visit TRIMIRA™ at: www.trimira.net
Animations
Identafi® Technology
Identafi® 3000 ultra Process
Screening Results
Training
